A low prevalence of coronary heart disease among subjects with increased high-density lipoprotein cholesterol levels, including those with plasma cholesteryl ester transfer protein deficiency

被引:134
作者
Moriyama, Y
Okamura, T
Inazu, A
Doi, M
Iso, H
Mouri, Y
Ishikawa, Y
Suzuki, H
Iida, M
Koizumi, J
Mabuchi, H
Komachi, Y
机构
[1] Kochi Prefectural Inst Publ Hlth, Kochi 7800850, Japan
[2] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Epidemiol & Mass Examinat Cardiovasc Dis, Osaka, Japan
[3] Kanazawa Univ, Fac Med, Sch Med, Dept Internal Med 2, Kanazawa, Ishikawa 9200942, Japan
[4] Kochi Prefectural Off, Dept Hlth & Welf, Kochi, Japan
[5] Univ Tsukuba, Inst Community Med, Tsukuba, Ibaraki 305, Japan
[6] Osaka Prefectural Inst Publ Hlth, Osaka 537, Japan
关键词
cholesterol; cholesteryl ester transfer protein deficiency; coronary heart disease; genetic epidemiology; high-density lipoprotein;
D O I
10.1006/pmed.1998.0340
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background. Use of genetic analysis may improve the predictive value of risk factors for disease. A high plasma level of high-density lipoprotein (HDL) cholesterol is a strong negative risk factor for coronary heart disease (CHD). Cholesteryl ester transfer protein (CETP) deficiency causes increased levels of HDL cholesterol, However, recent studies suggest that CETP deficiency is a risk factor for CHD despite elevated HDL cholesterol levels, Methods. Plasma lipid levels, CHD prevalence, resting electrocardiograms, and common CETP gene mutations were analyzed cross-sectionally in a population of 19,044 male and 29,487 female Japanese subjects (ages 45-79 years). Results. High HDL cholesterol levels (serum HDL cholesterol greater than or equal to 80 mg/dl, greater than or equal to 95th percentile) were found in 6 and 5% of Japanese men and women, respectively. In the group with HDL cholesterol greater than or equal to 80 mg/dl, common CETP gene mutations were identified in 23-24% of men and 31-49% of women. The prevalence of CHD in the group with high HDL cholesterol (greater than or equal to 80 mg/dl) was low among both men (1.0%) and women (1.3%). There was no difference in CHD prevalence between hyper-HDL-cholesterolemic subjects with and without CETP mutations. Conclusions. Subjects with very high HDL levels (HDL cholesterol greater than or equal to 80 mg/dl) as well as mild-to-moderate HDL elevations (60-79 mg/dl) appear to be protected against CHD, whether or not they have CETP deficiency, a genetic cause of elevated HDL. (C) 1998 American Health Foundation and Academic Press.
引用
收藏
页码:659 / 667
页数:9
相关论文
共 46 条
[11]   EVALUATION OF PATHWAYS FOR THE CELLULAR UPTAKE OF HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL ESTERS IN RABBITS [J].
GOLDBERG, DI ;
BELTZ, WF ;
PITTMAN, RC .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (01) :331-346
[12]   HIGH-DENSITY LIPOPROTEIN AS A PROTECTIVE FACTOR AGAINST CORONARY HEART-DISEASE - FRAMINGHAM STUDY [J].
GORDON, T ;
CASTELLI, WP ;
HJORTLAND, MC ;
KANNEL, WB ;
DAWBER, TR .
AMERICAN JOURNAL OF MEDICINE, 1977, 62 (05) :707-714
[13]  
Han K. H., 1996, KOREAN CIRC J, V26, P500
[14]  
HANNUKSELA M, 1992, J LIPID RES, V33, P737
[15]   Clinical characteristics of double heterozygotes with familial hypercholesterolemia and cholesteryl ester transfer protein deficiency [J].
Haraki, T ;
Inazu, A ;
Yagi, K ;
Kajinami, K ;
Koizumi, J ;
Mabuchi, H .
ATHEROSCLEROSIS, 1997, 132 (02) :229-236
[16]   ATHEROSCLEROTIC DISEASE IN MARKED HYPERALPHALIPOPROTEINEMIA - COMBINED REDUCTION OF CHOLESTERYL ESTER TRANSFER PROTEIN AND HEPATIC TRIGLYCERIDE LIPASE [J].
HIRANO, K ;
YAMASHITA, S ;
KUGA, Y ;
SAKAI, N ;
NOZAKI, S ;
KIHARA, S ;
ARAI, T ;
YANAGI, K ;
TAKAMI, S ;
MENJU, M ;
ISHIGAMI, M ;
YOSHIDA, Y ;
KAMEDATAKEMURA, K ;
HAYASHI, K ;
MATSUZAWA, Y .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (11) :1849-1856
[17]   Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan - Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity [J].
Hirano, K ;
Yamashita, S ;
Nakajima, N ;
Arai, T ;
Maruyama, T ;
Yoshida, Y ;
Ishigami, M ;
Sakai, N ;
KamedaTakemura, K ;
Matsuzawa, Y .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (06) :1053-1059
[18]  
Hui Shu-Ping, 1997, Hokkaido Journal of Medical Science, V72, P319
[19]   GENETIC CHOLESTERYL ESTER TRANSFER PROTEIN-DEFICIENCY CAUSED BY 2 PREVALENT MUTATIONS AS A MAJOR DETERMINANT OF INCREASED LEVELS OF HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL [J].
INAZU, A ;
JIANG, XC ;
HARAKI, T ;
YAGI, K ;
KAMON, N ;
KOIZUMI, J ;
MABUCHI, H ;
TAKEDA, R ;
TAKATA, K ;
MORIYAMA, Y ;
DOI, M ;
TALL, A .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (05) :1872-1882
[20]   INCREASED HIGH-DENSITY-LIPOPROTEIN LEVELS CAUSED BY A COMMON CHOLESTERYL-ESTER TRANSFER PROTEIN GENE MUTATION [J].
INAZU, A ;
BROWN, ML ;
HESLER, CB ;
AGELLON, LB ;
KOIZUMI, J ;
TAKATA, K ;
MARUHAMA, Y ;
MABUCHI, H ;
TALL, AR .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (18) :1234-1238